LLY News and Press, Eli Lilly and Company From 06/17/24

2024-06-17 09:13:40 ET Summary Viking Therapeutics shows promise with their VK2735 drug demonstrating significant weight loss in Phase 2 trials. Despite strong data, Viking faces intense competition and strategic challenges in a market dominated by Novo Nordisk and Eli Lilly. ...

2024-06-16 12:33:31 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: The Road To Approval Of Donanemab Is Open Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? ...

2024-06-16 12:05:00 ET If you're eyeing an investment in Madrigal Pharmaceuticals (NASDAQ: MDGL) , now's the time to imagine a representative of Eli Lilly (NYSE: LLY) interrupting your train of thought by saying something along the lines of, "Not so fast." While the biotech ...

2024-06-15 14:05:00 ET Developing brand-new drugs is a long and expensive process that doesn't always deliver a positive return on investment. Occasionally, some pharmaceutical companies hit the jackpot and launch medicines worth all that trouble. That's what Eli Lilly (NYSE: LLY) h...

2024-06-15 11:19:01 ET More on Eli Lilly, Novo Nordisk, etc. Eli Lilly: The Road To Approval Of Donanemab Is Open Teva Pharmaceutical Industries Limited (TEVA) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Eli Lilly and Company (LLY) Goldman Sac...

2024-06-15 07:15:00 ET Eli Lilly 's (NYSE: LLY) name has become somewhat synonymous with its work in diabetes and obesity care. That's understandable. The drugmaker is a leader in these areas, and its most recent medicines, Mounjaro and Zepbound, promise to rack up impressive sales....

2024-06-15 06:50:00 ET Have you ever felt anxiety about clicking the final button to buy a stock? Some investors agonize over their decisions. It doesn't have to be that way, though, if you find the right stocks. Three Motley Fool contributors believe they've identified good picks -- an...

2024-06-14 18:24:23 ET More on Eli Lilly, Novartis, etc. Eli Lilly: The Road To Approval Of Donanemab Is Open Eli Lilly and Company (LLY) Goldman Sachs 45th Annual Global Healthcare Conference Is It Possible Eli Lilly Is Breaking Out To New All-Time Highs? Em...

2024-06-14 17:53:40 ET Summary Vanguard Health Care ETF focuses on investing in successful healthcare companies with $20 billion in assets and a low expense ratio of 0.10%. Top holdings include Eli Lilly, UnitedHealth Group, and Johnson & Johnson, offering potential for growth...

2024-06-14 12:31:42 ET With the first half of 2024 almost in the books, investors will notice that 10 of the 11 S&P 500 ( SP500 ) sectors are higher on the year and only two segments are topping the YTD return of Wall Street's benchmark index.... Read the full article on Seeki...